These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 20514922

  • 1. The role of cytotoxic drugs in the treatment of central nervous system gliomas.
    Neyns B, D'haeseleer M, Rogiers A, Van de Cauter J, Chaskis C, Michotte A, Strik H.
    Acta Neurol Belg; 2010 Mar; 110(1):1-14. PubMed ID: 20514922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB.
    J Clin Oncol; 2003 Jun 15; 21(12):2299-304. PubMed ID: 12805330
    [Abstract] [Full Text] [Related]

  • 7. [A practical guide for the management of gliomas].
    Stupp R, Pica A, Mirimanoff RO, Michielin O.
    Bull Cancer; 2007 Sep 15; 94(9):817-22. PubMed ID: 17878102
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD, Taillandier L, Bernier V, Carnin C.
    Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):171-5. PubMed ID: 19352662
    [Abstract] [Full Text] [Related]

  • 10. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M.
    Acta Neuropathol; 2010 Nov 15; 120(5):585-92. PubMed ID: 20862485
    [Abstract] [Full Text] [Related]

  • 11. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM.
    Oncologist; 1997 Nov 15; 2(1):I-II. PubMed ID: 10388032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy.
    Florian IS, Tomuleasa C, Soritau O, Timis T, Ioani H, Irimie A, Kacso G.
    J BUON; 2011 Nov 15; 16(1):16-23. PubMed ID: 21674845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recent developments in the use of chemotherapy in brain tumours.
    van den Bent MJ, Hegi ME, Stupp R.
    Eur J Cancer; 2006 Mar 15; 42(5):582-8. PubMed ID: 16427778
    [Abstract] [Full Text] [Related]

  • 18. Low-grade gliomas.
    Ruiz J, Lesser GJ.
    Curr Treat Options Oncol; 2009 Aug 15; 10(3-4):231-42. PubMed ID: 19381819
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.